ALXO ALX Oncology
- 1.850
- -0.010-0.54%
- 1.820
- -0.030-1.62%
ALX Oncology News
ALX Oncology | 8-K: ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
ALX Oncology | 10-Q: Q3 2024 Earnings Report
ALX Oncology | 10-Q: Q2 2024 Earnings Report
ALX Oncology | 8-K: ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
ALX Oncology | 10-Q: Q1 2024 Earnings Report
ALX Oncology | 8-K: ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
ALX Oncology | 10-K: FY2023 Annual Report
ALX Oncology | 8-K: ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
ALX Oncology | 10-Q: Q3 2023 Earnings Report
ALX Oncology | 8-K: ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
ALX Oncology | 10-Q: Q2 2023 Earnings Report
ALX Oncology | 10-Q: Q1 2023 Earnings Report
ALX Oncology | 8-K: ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
ALX Oncology | 10-K: FY2022 Annual Report
ALX Oncology | 8-K: ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
ALX Oncology | 10-Q: Q3 2022 Earnings Report
ALX Oncology | 8-K: ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
ALX Oncology | 10-Q: Q2 2022 Earnings Report
ALX Oncology | 8-K: ALX Oncology Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
ALX Oncology | 10-Q: Q1 2022 Earnings Report
No Data